Assay for detection of human parvovirus nucleic acid

US10087494B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10087494-B2
Application numberUS-201414569338-A
CountryUS
Kind codeB2
Filing dateDec 12, 2014
Priority dateFeb 26, 2009
Publication dateOct 2, 2018
Grant dateOct 2, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Nucleic acid oligomers specific for human parvovirus genomic DNA are disclosed. An assay for amplifying and detecting human parvovirus genotypes 1, 2 and 3 nucleic acid in biological specimens is disclosed. Compositions for amplifying and detecting the presence of human parvovirus genotypes 1, 2 and 3 genomic DNA in human biological specimens are disclosed.

First claim

Opening claim text (preview).

I claim: 1. An amplification oligomer combination for amplifying human parvovirus genotypes 1, 2, and 3, the oligomer combination comprising: a) at least one primer oligomer member comprising a target binding sequence that is SEQ ID NO:48 or SEQ ID NO:50; b) a first promoter-based oligomer member comprising a sequence that is SEQ ID NO:73; and c) a second promoter-based oligomer member comprising a sequence that is SEQ ID NO:78. 2. An amplification oligomer combination for amplifying human parvovirus genotypes 1, 2, and 3, the oligomer combination comprising at least one primer oligomer member and at least one promoter-based oligomer member, wherein the at least one primer oligomer member and the at least one promoter-based oligomer member hybridize to opposing strands of a human parvovirus genotype 1, 2 or 3 nucleic acid or amplicon thereof for transcription mediated amplification of the target nucleic acid or amplicon thereof between the hybridized primer and promoter-based oligomer members, wherein A) the at least one promoter-based oligomer member is a first promoter-based oligomer member that is SEQ ID NO:76 and a second promoter-based oligomer member that is SEQ ID NO:81; B) the at least one promoter-based oligomer member is selected from the group consisting of SEQ ID NOS:58, 63, 67, 68, 73, 78, 82, and combinations thereof; C) the at least one primer oligomer member is SEQ ID NO:50 and the at least one promoter-based oligomer member is a first promoter-based oligomer member that is SEQ ID NO:73 and a second promoter-based oligomer member that is SEQ ID NO:78; or D) the at least one primer oligomer member is SEQ ID NO:47 and the at least one promoter-based oligomer member is selected from the group consisting of SEQ ID NOs:73, 76, 78, 81 and combinations thereof. 3. The amplification oligomer combination of claim 1 , wherein the at least one primer oligomer member comprises the target-binding sequence that is SEQ ID NO:50. 4. The amplification oligomer combination of claim 1 , wherein the at least one primer oligomer member comprises the target-binding sequence that is SEQ ID NO:48. 5. The amplification oligomer combination of claim 1 , wherein the at least one primer oligomer member is SEQ ID NO:47. 6. The amplification oligomer combination of claim 1 , wherein the at least one primer member is selected from the group consisting of SEQ ID NO:47, SEQ ID NO:48, SEQ ID NO:49, SEQ ID NO:50 and combinations thereof. 7. A reaction mixture for performing a transcription mediated amplification reaction, wherein the reaction mixture comprises: a) an amplification oligomer combination comprising: i) at least one primer oligomer member comprising a target binding sequence that is SEQ ID NO:48 or SEQ ID NO:50; ii) a first promoter-based oligomer member comprising a sequence that is SEQ ID NO:73; and iii) a second promoter-based oligomer member comprising a sequence that is SEQ ID NO:78; and b) an enzyme comprising an activity selected from the group consisting of reverse transcriptase activity, RNA polymerase activity, and RNase H activity. 8. The reaction mixture of claim 7 , wherein the enzyme comprises reverse transcriptase activity and RNase H activity. 9. The amplification oligomer combination of claim 2 , wherein the at least one promoter-based oligomer member comprises a blocking moiety at its 3′ end.

Assignees

Inventors

Classifications

  • Polymerase chain reaction [PCR] · CPC title

  • Expression markers · CPC title

  • C12Q1/701Primary

    Specific hybridization probes · CPC title

  • C12Q1/702Primary

    for retroviruses · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10087494B2 cover?
Nucleic acid oligomers specific for human parvovirus genomic DNA are disclosed. An assay for amplifying and detecting human parvovirus genotypes 1, 2 and 3 nucleic acid in biological specimens is disclosed. Compositions for amplifying and detecting the presence of human parvovirus genotypes 1, 2 and 3 genomic DNA in human biological specimens are disclosed.
Who is the assignee on this patent?
Gen Probe Inc
What technology area does this patent fall under?
Primary CPC classification C12Q1/701. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).